Clinical Trials Sponsored by Tikun Olam

Total 63 results

Assaf-Harofeh Medical Center
Tikun Olam

Withdrawn

Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) (ICON-HP)

Hemodialysis | Protein-Energy Malnutrition | Appetite Disorders

Israel
Pharm Olam Pharmaceuticals Ltd.

Unknown

PraevoSkin Emulsion in the Prevention of Radiation Induced Dermatitis

Prevention of Radiation Induced Dermatitis.
Persephone Biosciences
Pharm-Olam International

Recruiting

Development and Analysis of a Stool Bank for Cancer Patients

Carcinoma, Non-Small-Cell Lung | Carcinoma, Colorectal

United States
Circassia Limited
Pharm-Olam International

Completed

House Dust Mite Observational Study

Rhinoconjunctivitis

Canada
Seres Therapeutics, Inc.
Pharm-Olam International

Completed

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Clostridium Difficile Infection

United States
Helix BioPharma Corporation
Pharm-Olam International

Completed

A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47

Non-Small Cell Lung Cancer

Poland
Nerre Therapeutics Ltd.
Pharm-Olam International

Active, not recruiting

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis (IPF-COMFORT)

Cough | Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Netherlands
Circassia Limited
inVentiv Health Clinical; Pharm-Olam International

Completed

Phase III Cat-PAD Study

Rhinoconjunctivitis

United States, Poland, Germany, Belgium, Canada, Russian Federation, Hungary, Slovakia, Czechia
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Exposure Unit Study

Grass Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis
Pharm-Olam, LLC
Biomedical Advanced Research and Development Authority

Terminated

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents (CoVacSpec)

COVID-19

United States, South Africa, Colombia, Guadeloupe, India, Mexico, Puerto Rico
Lars Olaf Cardell

Completed

Is Intralymphatic Allergen Immunotherapy Effective and Safe?

Allergic Rhinitis Due to Grass Pollen

Sweden
Lars Olaf Cardell

Recruiting

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT (ILIT vs SLIT)

Allergic Rhinitis Due to Grass Pollen

Sweden
Lars Olaf Cardell

Completed

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

Allergic Rhinitis

Sweden
Ilam University of Medical Sciences

Terminated

Treatment of Acute Pancreatitis With Ketorolac

Acute Pancreatitis

Iran, Islamic Republic of
Ilam University of Medical Sciences

Completed

Prevention of Type 2 Diabetes Mellitus by Changes in Diet

Prediabetes
Ilam University of Medical Sciences

Completed

Efficacy of Vitamin C Administration for the Prevention of Postpolypectomy Bleeding

Postpolypectomy Bleeding

Iran, Islamic Republic of
Ilam University of Medical Sciences

Completed

The Effect of Educational Intervention on Delivery Type Selection in Pregnant Women at Kermanshah, Iran

Pregnancy
Ology Bioservices
Pharm-Olam, LLC; Chemical, Biological, Radiological, and Nuclear Medical

Withdrawn

Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT) (COMBAAT)

Mild to Moderate COVID-19
Marnix Lam

Completed

Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases (LUTIA)

Neuroendocrine Tumors | Liver Metastases

Netherlands
SLAM Ortho B.V.
Erasmus Medical Center

Recruiting

Usability of the ADEPTH Sensor for Bore Depth Measurements in Plate Osteosynthesis Procedures (ADEPTH-Pilot)

Fractures, Bone | Osteosynthesis

Netherlands
Dr. Hasan Alam

Terminated

A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)

Trauma | Shock,Hemorrhagic

United States
Dr. Hasan Alam

Completed

A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)

Shock,Hemorrhagic

United States
Byron Lam

Completed

Choroideremia Gene Therapy Clinical Trial

Choroideremia

United States
Dr. Asim Alam

Withdrawn

Zero Heat Flux Temp Monitor on Discharge Hypothermia Among Trauma Patients (RUZIT Trial) (RUZIT)

Trauma | Hypothermia | Temperature Change, Body

Canada
Per-Ola Carlsson

Completed

Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes

Type 1 Diabetes

Sweden
Monash University
Lam Wah Ee Hospital

Completed

Adjunct Inversion for Lower Pole Stone

Kidney Stone
Ola Adel Abdelfadil Ahmed

Not yet recruiting

Caries Arresting in Primary Molar Teeth Using SDF VS ART

Dental Caries
University of Pennsylvania
The LAM Foundation

Completed

Safety of Simvastatin in LAM and TSC (SOS)

Tuberous Sclerosis Complex | Lymphangioleiomyomatosis

United States
Ola Kamal Mohammed Galal

Not yet recruiting

Percutaneous Versus EUS FNAC in Pancreatic Masses

Pancreatic Cyst | Pancreatic Neoplasm | Pancreatic Abscess
Per-Ola Carlsson

Completed

Brown Adipose Tissue in Type 1 Diabetes

Type1diabetes

Sweden
Per-Ola Carlsson

Completed

[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes

Type2 Diabetes
Zahra Vahdat Shariatpanahi

Completed

Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Helicobacter Infection

Iran, Islamic Republic of
ola mohamed elsayed mostafa elgohary
Cairo University

Unknown

EFFECT OF AEROBIC TRAINING VERSUS MYOFACIAL RELEASE ON CLAUDICATION AMONG PREPHERAIL ARTERAIL INSUFFIECENCY PATIENTS

Peripheral Arterial Disease

Egypt
University of Hawaii
University of Washington; I Ola Lahui, Inc.; Ke Ola Mamo; Hui No Ke Ola Pono, Inc. and other collaborators

Unknown

The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians (KaHOLO)

Hypertension

United States
Vanderbilt University Medical Center
The LAM Foundation

Completed

Glutamine PET Imaging in LAM

Lymphangioleiomyomatosis (LAM)

United States
Per-Ola Carlsson
Sana Biotechnology

Not yet recruiting

First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes

Type1diabetes
Stephen Chan Lam

Recruiting

CXD101 in Immunotherapy-related Liver Cancer

HCC

Hong Kong
Stephen Chan Lam

Active, not recruiting

Cabozantinib in Hepatocellular Carcinoma

HCC

Korea, Republic of, Hong Kong
Byron Lam
National Eye Institute (NEI)

Active, not recruiting

Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON)

Leber's Hereditary Optic Neuropathy

United States
Per-Ola Carlsson
Diamyd Medical AB

Completed

Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

Type 1 Diabetes Mellitus

Sweden
Mikael Elam
Chalmers University of Technology; Medfield Diagnostics

Recruiting

Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase

Stroke

Sweden
Ola Alaa El-Din Abd El-Monem Mohamed
Cairo University

Completed

Ridge Augmentation Using Patient Specific PEEK Sheets vs. Autogenous Bone Shell Technique.

Ridge Deficiency

Egypt
Carl Ola Landgren, MD, PhD
Bristol-Myers Squibb

Recruiting

Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma (Iber-KDd)

Refractory Multiple Myeloma | Relapsed Multiple Myeloma

United States
Children's Hospital Medical Center, Cincinnati
The LAM Foundation; Tuberous Sclerosis Alliance

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Tuberous Sclerosis | Lymphangioleiomyomatosis

United States
Monash University
Klinik Kesihatan Puchong; Klinik Kesihatan Kelana Jaya; Klinik Kesihatan Shah... and other collaborators

Withdrawn

Pharmacist Enhanced Service for Cardiovascular Risk Reduction

Cardiovascular Risk Factor

Malaysia
University of Hawaii
Queen's Medical Center; I Ola Lahui, Inc.; Ke Ola Mamo; Queen Lili'uokalani Children... and other collaborators

Completed

PILI at Work a 5-Year Controlled Intervention Trial: Testing DVD Versus Group Delivery of a Weight-Loss Maintenance Intervention in Native Hawaiian- Serving Worksites (P@W)

Obesity | Overweight | Weight Loss | Weight Loss Maintenance

United States
Carl Ola Landgren, MD, PhD
Janssen Scientific Affairs, LLC

Recruiting

Teclistamab or Talquetamab in Combination With Daratumumab for High-Risk Smoldering Myeloma (REVIVE Study) (REVIVE)

Multiple Myeloma

United States
Lam Cu Phong

Completed

Effect of Platelet-rich Fibrin on Soft Tissue, Periodontal Pocket Healing and Alveolar Bone Height After Third Molar Surgery

Platelet-rich Fibrin

Vietnam
Ola Blennow, MD, PhD
Karolinska University Hospital; Danderyd Hospital; Centrallasarettet Västerås

Active, not recruiting

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) (HALT)

Pneumonia, Viral | Covid-19 | Sars-CoV2

Sweden

Clinical Trials Sponsored by Tikun Olam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations